Breast Cancer Clinical Trials

Showing 3001-3020 of 4,817 trials

Testing of the Cancer Thriving and Surviving Breast Cancer Program

NCT03651921

The adjusted Cancer Thriving and Surviving Program (CTS) for women with breast cancer living in Switzerland (CTS-BC-CH) is a course of 7 weekly sessions of 2.5 - 3 hours led by trained peer-leaders (women with breast cancer experience). This pilot study aims to explore the reach of the CTS-BC-CH program (integrated into the clinical pathway) and to investigate its preliminary effectiveness with regard to Swiss breast cancer patients' self-efficacy and self-management.

Breast NeoplasmEarly-Stage Breast CancerSelf-Management+2 more

Manuela Eicher39 participantsStarted Dec 2017

Basel, Switzerland • Bern, Switzerland

UNKNOWN

Clinical Study of Imaging Genomics Based on Machine Learning for BCIG

NCT04461990

1. Identify the imaging features of breast cancer with different molecular types 2. Reveal the association between hormone receptor positive/HER2 negative breast cancer and imaging histology, Oncotype Dx recurrence score 3. Combine genomics and imaging to establish a predictive model for the sensitivity of HER2-positive breast cancer targeted therapy 4. Establish an imaging genomics prediction model for triple-negative breast cancer molecular subtypes, and clarify the imaging genomics characteristics of the therapeutic targets of each subtype

Breast CancerMolecular TypingPathology+1 more

Fudan University1,500 participantsStarted Dec 2020

Shanghai, Shanghai Municipality, China

WITHDRAWNPhase 2

Ixabepilone and SBRT For Metastatic Breast Cancer

NCT01818999

This study is being done to find the effect of Stereotactic body radiation therapy (SBRT) in combination with Ixabepilone for women with triple negative metastatic breast cancer.

METASTATIC BREAST CANCER

University of Texas Southwestern Medical CenterStarted Aug 2013

Dallas, Texas, United States

Testing of the Cancer Thriving and Surviving Breast Cancer Program

Clinical Study of Imaging Genomics Based on Machine Learning for BCIG

Ixabepilone and SBRT For Metastatic Breast Cancer

Related Searches

e-CHEC-uP: Scaling up an Efficacious Cancer Screening Intervention for Women With Limited English

Trial Evaluating the Benefit of a Fitness Tracker Based Workout During Adjuvant Radiotherapy of Breast Cancer

Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer

Accelerated Intensity Modulated Radiation Therapy (AIMRT) to the Breast After Segmental Mastectomy

Quantitative Evaluation of the Breast's Morphological Variations During Radiotherapy: MorphoBreast3D

Study of TTC-352 in Patients With Metastatic Breast Cancer Progressing on Endocrine Therapy

Characterization & Comparison of Drugable Mutations in Primary and Metastatic Tumors, CTCs and cfDNA in MBCpatients

Hypnosis for Patients Treated With Adjuvant Chemotherapy for Breast Cancer(HYPNOVAL)

Implementation and Evaluation of a Social Journey Accompanied in Breast Cancer Diagnosis (EPARS SEIN)

Enzastaurin in Combination of Capecitabine to Treat Breast Cancer

Evaluation of the Efficacy of Digital Breast Tomosynthesis Imaging

Study Comparing Whole Breast Radiotherapy With a Daily Versus a Weekly Tumor

Durvalumab and Eribulin in Her2-negative Metastatic Breast Cancer and Recurrent Ovarian Cancer

A Prospective Cohort Study of Occupational Exposures and Cancer Risk Among Women

GW572016 and Trastuzumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2/Neu

Vaccine Therapy in Treating Women With Previously Treated Metastatic Breast Cancer

Effect of Intravaginal Prasterone on Symptoms of VVA in Women Under Treatment With an Aromatase Inhibitor for Breast Cancer